Erudio Healtherudio.com
Sponsor
Nuvalent trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Nuvalent yet. Erudio has found public clinician commentary on 4 clinical trials sponsored by Nuvalent: ALKAZAR, ALKOVE-1, ARROS-1 and HEROEX-1. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Nuvalent Inc.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| ALKOVE-1 NCT05384626 · Nuvalent Inc. DeepView → | advanced solid tumors harboring ALK rearrangement or mutation | Phase 1/Phase 2 | Deep | View | |||
| ALKAZAR NCT06765109 · Nuvalent Inc. DeepView → | first-line ALK-positive advanced non-small cell lung cancer | Phase 3 | Deep | View | |||
| ARROS-1 NCT05118789 · Nuvalent Inc. StandardView → | Not given | Phase 1/Phase 2 | Standard | View | |||
| HEROEX-1 NCT06521554 · Nuvalent Inc. FocusedView → | Not given | Phase 1 | Focused | View | |||